Venus Remedies forays into consumer healthcare market; share price takes a leap

Vishwajeet Bhandigare
/ Categories: Mindshare, DSIJ News
Venus Remedies forays into consumer healthcare market; share price takes a leap

Venus Remedies Ltd started off with the new consumer healthcare division today by entering into a 30,000 crore consumer healthcare market. This research-driven pharmaceutical company plans to introduce a series of products that would aid pain management, gastroenterology, hygiene, stress management, and vitamins along with supplements segments.  

To start with, the company has come up with a pain management solution called R3SET. The consumer healthcare sector is expected to grow at 12-15 per cent annually while the pain management segment forms about 30 per cent of the size of this industry; the largest among all.   

The stock price today closed at its upper circuit of 5 per cent at Rs 465.15 on BSE.  

Venus Remedies Ltd operates in the pharmaceutical industry, especially in critical care segment, in which, it manufactures super-speciality injectable formulations.  

The stock is trading near its 52-week high of Rs 471. Besides, its 52-week low is Rs 55.15.

Rate this article:
5.0

Leave a comment

Add comment

DSIJ MINDSHARE

Mkt Commentary31-Oct, 2024

Mindshare31-Oct, 2024

Mindshare31-Oct, 2024

Mkt Commentary31-Oct, 2024

Mindshare31-Oct, 2024

Knowledge

MF28-Oct, 2024

Personal Finance28-Oct, 2024

Technical23-Oct, 2024

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR